Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atypical Antipsychotics Maintenance in Bipolar Mania
NCT01977300Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Jan 2003
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of risperidone and olanzapine in bipolar I disorder (3 arms), sponsored by University of British Columbia. Primary endpoint: Time to any mood episode (depressive or manic) at 52 weeks. Started Jan 2003; status: completed.
02
Drugs
risperidoneolanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01977300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977300.